| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Former 10% Owner +1 more
17 companies
Baker Bros. Advisors LP is a Director, 10% Owner at ACADIA PHARMACEUTICALS INC with holdings across 17 companies. Recent SEC Form 4 filings include 122 buys and 2 sells.
Estimated insider holdings value: $7413.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | ONC Beone Medicines Ltd. | Director, 10% Owner | Sell | 1,100,000 | $180.50 | $198,550,000.00 | -9.4% | -27.3% | -3.0% | |
| Nov 14, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 107,499 | $146.99 | $15,801,021.17 | +0.4% | +38.3% | +101.4% | |
| Aug 17, 2023 | NGNE Neurogene Inc. | Director, 10% Owner | Buy | 2,285,342 | $0.64 | $1,463,486.73 | +6.9% | -4.7% | +141.9% | |
| May 24, 2023 | ACAD Acadia Pharmaceuticals Inc | Director, 10% Owner | Buy | 896,522 | $25.33 | $22,707,097.58 | +0.3% | +13.4% | -39.4% | |
| Jun 6, 2022 | KOD Kodiak Sciences Inc. | Director, 10% Owner | Buy | 572,349 | $7.77 | $4,448,168.04 | +0.6% | +19.9% | +17.9% | |
| Jun 6, 2022 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Buy | 40,947 | $6.37 | $260,759.62 | +0.3% | +110.3% | +112.1% | |
| May 27, 2022 | KOD Kodiak Sciences Inc. | Director, 10% Owner | Buy | 326,747 | $6.75 | $2,205,321.35 | +0.3% | +63.0% | -13.2% | |
| May 24, 2022 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Buy | 48,509 | $5.82 | $282,447.24 | +0.2% | +118.7% | +112.5% | |
| May 18, 2022 | KOD Kodiak Sciences Inc. | Director, 10% Owner | Buy | 456,690 | $5.91 | $2,696,829.07 | +0.4% | +96.8% | -11.0% | |
| May 18, 2022 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Buy | 71,944 | $5.99 | $430,700.75 | +0.4% | +105.0% | +109.3% |